Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 401–450 of 7,383 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04972097	Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue(PRESERVE)	completed	N/A	121	Angiodynamics, Inc.INDUSTRY	1	Jun 2, 2026	clinicaltrials
NCT05038137	Time Restricted Eating on Cancer Risk(TREC)	completed	N/A	29	Medical University of South CarolinaOTHER	1	Jun 2, 2026	clinicaltrials